The deal marks the second agreement between Sputnik V's developer and Indian drug manufacturers in a week. : The backer of Russia's Sputnik V coronavirus vaccine said Monday it had signed an agreement with an India-based pharmaceuticals giant for the production of up to 200 million doses of the jab a year. The Russian Direct Investment Fund (RDIF), the country's sovereign wealth fund, said in a statement it has partnered with the Virchow Group to produce up to 200 million doses of the two-dose vaccine in India every year.